The Daily Hit is a recap of the top financial news stories for Wednesday, December 18, 2024.
On the Site
Weedmaps co-founders bid to take company private
The co-founders offered a 39% premium for the company amid industry headwinds and regulatory challenges.
Vireo nabs $75M through 120M new shares, goes on acquisition spree
If all four acquisitions close, the deal will transform Vireo by more than doubling its marijuana industry footprint.
Marijuana activist leaders optimistic for progress in 2025
Two leaders of the Marijuana Policy Project said there are reasons to be hopeful heading into a second Trump presidency.
Michigan’s cannabis prices continue to free fall, spelling trouble for industry
Cannabis prices have fallen 87% since legalization in 2018.
Organigram tops estimates, expands international reach ahead of major deal
The Canadian cannabis producer saw its quarterly losses shrink by nearly 80%, as international expansion and efficiency gains pay off.
cbdMD posts lower annual sales, mixed fourth quarter
The CBD company said unaudited October and November revenues have already rebounded above fourth quarter levels.
In Other News
Flora Growth Corp.
On Dec. 15, 2024, Flora Growth Corp.’s Board of Directors granted Clifford Starke 900,000 Restricted Stock Awards that fully vested on the same day. Starke is the CEO of Flora Growth.
CBD Life Sciences
CBD Life Sciences. (OTC Pink: CBDL) reduced its authorized share count by a staggering 3.5 billion shares. By decreasing the number of authorized shares, CBDL aims to reduce dilution, increase stock value, and solidify its reputation as a company that prioritizes its shareholders’ interests.
[[{“value”:”News from: Weedmaps, Vireo Health, Michigan, Organigram and more.
The post The Daily Hit: December 18, 2024 appeared first on Green Market Report.”}]] Read More
